Series C - RayzeBio
Investment Firm
Overview
RayzeBio is a pharmaceuticals company that develops targeted radiopharmaceutical drugs for cancer.
Announced Date
Jun 15, 2021
Funding Type
Series C
Highlights
Location
United States, North America
Social
Investor Lead
N/A
Participant Investors
12
Round Details and Background
RayzeBio raised $108000000 on 2021-06-15 in Series C
RayzeBio is a pharmaceuticals company that develops targeted radiopharmaceutical drugs for cancer.
Company Funding History
4
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Oct 14, 2020 |  Series A - RayzeBio | 3 | - | 45.0M |
| Dec 08, 2020 | Series B - RayzeBio | 11 | - | 105.0M |
| Jun 15, 2021 | Series C - RayzeBio | 16 | - | 108.0M |
| Sep 13, 2022 | Series D - RayzeBio | 7 | - | 160.0M |
Recent Activity
There is no recent news or activity for this profile.